Literature DB >> 17949677

Detection and quantification of tau aggregation using a membrane filter assay.

Edward Chang1, Jeff Kuret.   

Abstract

Aggregation of the microtubule-associated protein tau contributes to the formation of neurofibrillary lesions in Alzheimer's disease and is a useful marker of disease progression. Although filter trap assays have been employed to assess the extent of tau aggregation in cells and tissues as well as in vitro, their performance relative to other assay modalities has not been reported. To clarify this issue, the ability of the filter trap approach to quantify aggregation of purified recombinant full-length tau protein in vitro was examined as a function of membrane chemistry in a 96-well format. Results showed that nitrocellulose yielded the greatest assay sensitivity relative to polyvinylidene fluoride or cellulose acetate at equal membrane porosity. However, all combinations of filter chemistries, porosities, and monoclonal detection antibodies yielded nonlinear correlations between signal intensity and analyte concentration. When corrected for nonlinearity, the filter trap assay determined a value for the critical monomer concentration for tau aggregation that was statistically identical to determinations made by electron microscopy assay. The data suggest conditions under which filter trap assays can be used to estimate tau aggregation kinetics.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17949677      PMCID: PMC2359897          DOI: 10.1016/j.ab.2007.09.015

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  33 in total

1.  Membrane filter assay for detection of amyloid-like polyglutamine-containing protein aggregates.

Authors:  E E Wanker; E Scherzinger; V Heiser; A Sittler; H Eickhoff; H Lehrach
Journal:  Methods Enzymol       Date:  1999       Impact factor: 1.600

2.  A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays.

Authors: 
Journal:  J Biomol Screen       Date:  1999

3.  Ligand-dependent tau filament formation: implications for Alzheimer's disease progression.

Authors:  M E King; V Ahuja; L I Binder; J Kuret
Journal:  Biochemistry       Date:  1999-11-09       Impact factor: 3.162

4.  The structural basis of monoclonal antibody Alz50's selectivity for Alzheimer's disease pathology.

Authors:  G Carmel; E M Mager; L I Binder; J Kuret
Journal:  J Biol Chem       Date:  1996-12-20       Impact factor: 5.157

5.  Functional implications for the microtubule-associated protein tau: localization in oligodendrocytes.

Authors:  P LoPresti; S Szuchet; S C Papasozomenos; R P Zinkowski; L I Binder
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

6.  Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo.

Authors:  E Scherzinger; R Lurz; M Turmaine; L Mangiarini; B Hollenbach; R Hasenbank; G P Bates; S W Davies; H Lehrach; E E Wanker
Journal:  Cell       Date:  1997-08-08       Impact factor: 41.582

7.  Recognition of the minimal epitope of monoclonal antibody Tau-1 depends upon the presence of a phosphate group but not its location.

Authors:  G I Szendrei; V M Lee; L Otvos
Journal:  J Neurosci Res       Date:  1993-02-01       Impact factor: 4.164

8.  Anionic micelles and vesicles induce tau fibrillization in vitro.

Authors:  Carmen N Chirita; Mihaela Necula; Jeff Kuret
Journal:  J Biol Chem       Date:  2003-05-01       Impact factor: 5.157

9.  Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution.

Authors:  H LeVine
Journal:  Protein Sci       Date:  1993-03       Impact factor: 6.725

10.  Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease.

Authors:  M Goedert; M G Spillantini; R Jakes; D Rutherford; R A Crowther
Journal:  Neuron       Date:  1989-10       Impact factor: 17.173

View more
  21 in total

1.  Nucleation-dependent tau filament formation: the importance of dimerization and an estimation of elementary rate constants.

Authors:  Erin E Congdon; Sohee Kim; Jonathan Bonchak; Tanakorn Songrug; Anastasios Matzavinos; Jeff Kuret
Journal:  J Biol Chem       Date:  2008-03-21       Impact factor: 5.157

2.  Assessment of proteasome impairment and accumulation/aggregation of ubiquitinated proteins in neuronal cultures.

Authors:  Natura Myeku; Maria Jose Metcalfe; Qian Huang; Maria Figueiredo-Pereira
Journal:  Methods Mol Biol       Date:  2011

3.  Azaphilones inhibit tau aggregation and dissolve tau aggregates in vitro.

Authors:  Smita R Paranjape; Andrew P Riley; Amber D Somoza; C Elizabeth Oakley; Clay C C Wang; Thomas E Prisinzano; Berl R Oakley; T Chris Gamblin
Journal:  ACS Chem Neurosci       Date:  2015-04-15       Impact factor: 4.418

4.  Hydralazine modifies Aβ fibril formation and prevents modification by lipids in vitro.

Authors:  Mukesh Maheshwari; Jessica K Roberts; Brent Desutter; Karen T Duong; Joseph Tingling; Janelle N Fawver; Hayley E Schall; Michael Kahle; Ian V J Murray
Journal:  Biochemistry       Date:  2010-11-17       Impact factor: 3.162

5.  Inhibition of Tau aggregation by three Aspergillus nidulans secondary metabolites: 2,ω-dihydroxyemodin, asperthecin, and asperbenzaldehyde.

Authors:  Smita R Paranjape; Yi-Ming Chiang; James F Sanchez; Ruth Entwistle; Clay C C Wang; Berl R Oakley; T Chris Gamblin
Journal:  Planta Med       Date:  2014-01-10       Impact factor: 3.352

6.  Defining α-synuclein species responsible for Parkinson's disease phenotypes in mice.

Authors:  Jessica M Froula; Marta Castellana-Cruz; Nadia M Anabtawi; José D Camino; Serene W Chen; Drake R Thrasher; Jennifer Freire; Allen A Yazdi; Sheila Fleming; Christopher M Dobson; Janet R Kumita; Nunilo Cremades; Laura A Volpicelli-Daley
Journal:  J Biol Chem       Date:  2019-05-29       Impact factor: 5.157

7.  The small heat shock proteins αB-crystallin (HSPB5) and Hsp27 (HSPB1) inhibit the intracellular aggregation of α-synuclein.

Authors:  Dezerae Cox; Heath Ecroyd
Journal:  Cell Stress Chaperones       Date:  2017-03-23       Impact factor: 3.667

Review 8.  Structure and mechanism of action of tau aggregation inhibitors.

Authors:  Katryna Cisek; Grace L Cooper; Carol J Huseby; Jeff Kuret
Journal:  Curr Alzheimer Res       Date:  2014       Impact factor: 3.498

9.  Ligand electronic properties modulate tau filament binding site density.

Authors:  Katryna Cisek; Jordan R Jensen; Nicolette S Honson; Kelsey N Schafer; Grace L Cooper; Jeff Kuret
Journal:  Biophys Chem       Date:  2012-09-11       Impact factor: 2.352

Review 10.  Tau aggregation and toxicity in tauopathic neurodegenerative diseases.

Authors:  Nicolette S Honson; Jeff Kuret
Journal:  J Alzheimers Dis       Date:  2008-08       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.